Write your message
Volume 11, Issue 6 (November-December 2017)                   IJT 2017, 11(6): 7-12 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Bahtouee M, Fatemikia H, Pourkhalili K, Kim E, Rahimi H R, Tavosi Z, et al . Saffron Protection against Bleomycin-Induced Pulmonary Fibrosis in Rats. IJT. 2017; 11 (6) :7-12
URL: http://ijt.arakmu.ac.ir/article-1-599-en.html
1- Department of Internal Medicine, Bushehr University of Medical Sciences, Bushehr, Iran.
2- Department of Physiology, Shiraz University of Medical Sciences, Shiraz, Iran.
3- Department of Physiology, Bushehr University of Medical Sciences, Bushehr, Iran.
4- Department of Toxicology, College of Veterinary Medicine, Gyeongsang National University, Jinju, South Korea.
5- Department of Pathology, Bushehr University of Medical Sciences, Bushehr, Iran.
6- Department of Biostatistics, Bushehr University of Medical Sciences, Bushehr,Iran.
7- MSc of Nutrition, Research Center, Bushehr University of Medical Science, Bushehr, Iran.
8- Department of Pharmacology, Bushehr University of Medical Sciences, Bushehr, Iran. , raminseyedian@gmail.com
Abstract:   (2378 Views)
Background: Bleomycin-induced lung fibrosis has been accepted as an animal model for fibrosis in rats. The aim of this study was to evaluate the effects of saffron aqueous extract on this disorder paving the way for more investigation in treating idiopathic pulmonary fibrosis in human. 
Methods: Male Wistar rats (250–300 gr) were instilled a single dose of bleomycin (5 mg/kg) via intratracheal tube (n=6) in 2015. Sham group received normal saline. Saffron aqueous extract (50 mg/kg and 100 mg/kg) were given orally in two different treated groups with bleomycin for 28 days. Lung Indices was calculated at the end of this experiment. Lung segments fixed in 10% formaldehyde were used for pathological preparation with Hematoxylin & Eosin and trichrome staining.
Results: The body weight was decreased and lung Indices increased in bleomycin group (P<0.5). Bleomycin administration increased myeloperoxidase, malondialdehyde and finally TNF-α in lung tissue homogenates (P<0.05) compared with sham group. The fibrotic process and thickening of alveolar septa in treated rats with bleomycin were increased by H&E and Masson Trichrome staining. Saffron treatment (50 and 100 mg/kg) attenuated the increase in MDA (264.43±10.4 nmol/g by the higher dose versus 378.4±18.1nmol/g), MPO (0.19±0.03 and 0.13± 0.04 IU/ml versus 0.39.2±0.05 IU/ml) and TNF-α level (18.42±3.7 ng/ml and14.31±3.6 ng /ml versus 35.32±4.2) in lung homogenates compared to bleomycin group (P<0.05). It decreased collagen accumulation and alveolar destructive patterns in pulmonary fibrosis.
Conclusion: This study introduces saffron as novel anti-fibrotic agent against bleomycin-induced fibrosis due to histological examinations and preventive effects on destructive enzyme release in rats.
Keywords: Bleomycin, Fibrosis, Rat, Saffron
Full-Text [PDF 493 kb]   (700 Downloads)    
Type of Study: Research | Subject: General

1. Benjamin I, Griggs RC, Wing EJ, Fitz JG. Andreoli and Carpenter\'s Cecil Essentials of Medicine E-Book: Elsevier Health Sciences; 2015.
2. Meltzer EB, Noble PW. Idiopathic pulmonary fibrosis. Orphanet J Rare Dis 2008;3(1):8-9. [DOI:10.1186/1750-1172-3-8]
3. Nalysnyk L, Cid-Ruzafa J, Rotella P, Esser D. Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature. Eur Respir Rev 2012;21(126):355-61. [DOI:10.1183/09059180.00002512]
4. Verma S, Slutsky AS. Idiopathic pulmonary fibrosis-new insights. N Engl J Med 2007;356(13):1370-2. [DOI:10.1056/NEJMcibr070490]
5. Abdullaev FI. Biological effects of saffron. BioFactors 1993;4(2):83-6.
6. Javadi B, Sahebkar A, Emami SA. A survey on saffron in major Islamic traditional medicine books. Iran J Basic Med Sci 2013;16(1):1-11.
7. Rios J, Recio M, Giner R, Manez S. An update review of saffron and its active constituents. Phytother Res 1996;10(3):189-93. https://doi.org/10.1002/(SICI)1099-1573(199605)10:3<189::AID-PTR754>3.0.CO;2-C [DOI:10.1002/(SICI)1099-1573(199605)10:33.0.CO;2-C]
8. Samarghandian S, Borji A, Farahmand SK, Afshari R, Davoodi S. Crocus sativus L.(saffron) stigma aqueous extract induces apoptosis in alveolar human lung cancer cells through caspase-dependent pathways activation. BioMed Res Int 2013;2013.
9. Hosseinzadeh H, Ghenaati J. Evaluation of the antitussive effect of stigma and petals of saffron (Crocus sativus) and its components, safranal and crocin in guinea pigs. Fitoterapia 2006;77(6):446-8. [DOI:10.1016/j.fitote.2006.04.012]
10. Spagnolo P, Maher T, Richeldi L. Idiopathic pulmonary fibrosis: recent advances on pharmacological therapy. Pharmacol Ther 2015;152:18-27. [DOI:10.1016/j.pharmthera.2015.04.005]
11. Idiopathic Pulmonary Fibrosis Clinical Research Network. Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N Engl J Med 2012;2012(366):1968-77.
12. King TE, Pardo A, Selman M. Idiopathic pulmonary fibrosis. Lancet 2011;378(9807):1949-61. [DOI:10.1016/S0140-6736(11)60052-4]
13. Assimopoulou A, Sinakos Z, Papageorgiou V. Radical scavenging activity of Crocus sativus L. extract and its bioactive constituents. Phytother Res 2005;19(11):997-1000. [DOI:10.1002/ptr.1749]
14. Moore BB, Hogaboam CM. Murine models of pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 2008;294(2):L152-L60. [DOI:10.1152/ajplung.00313.2007]
15. Moeller A, Rodriguez-Lecompte JC, Wang L, Gauldie J, Kolb M. Models of pulmonary fibrosis. Drug Discov Today Dis Models 2006;3(3):243-9. [DOI:10.1016/j.ddmod.2006.09.006]
16. Xu M, Deng B, Chow Y-l, Zhao Z-z, Hu B. Effects of curcumin in treatment of experimental pulmonary fibrosis: a comparison with hydrocortisone. J Ethnopharmacol 2007;112(2):292-9. [DOI:10.1016/j.jep.2007.03.011]
17. Asdaq SMB, Inamdar MN. Potential of Crocus sativus (saffron) and its constituent, crocin, as hypolipidemic and antioxidant in rats. Appl Biochem Biotechnol 2010;162(2):358-72. [DOI:10.1007/s12010-009-8740-7]
18. Mehdizadeh R, Parizadeh MR, Khooei A-R, Mehri S, Hosseinzadeh H. Cardioprotective effect of saffron extract and safranal in isoproterenol-induced myocardial infarction in wistar rats. Iran J Basic Med Sci 2013;16(1):56.
19. Chen L, Zhao W. Apigenin protects against bleomycin induced lung fibrosis in rats. Exp Ther Med 2016;11(1):230-4. [DOI:10.3892/etm.2015.2885]
20. Lev E, Amar Z. \"Fossils\" of practical medical knowledge from medieval Cairo. J Ethnopharmacol 2008;119(1):24-40. [DOI:10.1016/j.jep.2008.05.042]
21. Hosseinzadeh H, Younesi HM. Antinociceptive and anti-inflammatory effects of Crocus sativus L. stigma and petal extracts in mice. BMC Pharmacol 2002;2(1):1-8. [DOI:10.1186/1471-2210-2-1]
22. Kilic T, Parlakpinar H, Polat A, Taslidere E, Vardi N, Sarihan E, et al. Protective and therapeutic effect of molsidomine on bleomycin-induced lung fibrosis in rats. J Inflamm 2014;37(4):1167-78. [DOI:10.1007/s10753-014-9841-1]
23. Williamson JD, Sadofsky LR, Hart SP. The pathogenesis of bleomycin-induced lung injury in animals and its applicability to human idiopathic pulmonary fibrosis. Exp Lung Res 2015;41(2):57-73. [DOI:10.3109/01902148.2014.979516]
24. Şener G, Topaloğlu N, Şehirli AÖ, Ercan F, Gedik N. Resveratrol alleviates bleomycin-induced lung injury in rats. Pulm Pharmacol Ther 2007;20(6):642-9. [DOI:10.1016/j.pupt.2006.07.003]
25. Samarghandian S, Azimi-Nezhad M, Samini F. Ameliorative effect of saffron aqueous extract on hyperglycemia, hyperlipidemia, and oxidative stress on diabetic encephalopathy in streptozotocin induced experimental diabetes mellitus. BioMed Res Int 2014;2014.
26. Punithavathi D, Venkatesan N, Babu M. Protective effects of curcumin against amiodarone induced pulmonary fibrosis in rats. Br J Pharmacol 2003;139(7):1342-50. [DOI:10.1038/sj.bjp.0705362]
27. Turgut NH, Kara H, Elagoz S, Deveci K, Gungor H, Arslanbas E. The protective effect of naringin against bleomycin-induced pulmonary fibrosis in wistar rats. Pulm Med 2016;2016.
28. Laight DW, Lab N, Woodward B, Waterfall JF. Assessment of myeloperoxidase activity in renal tissue after ischaemia reperfusion. Eur J Pharmacol 1994;292(1):81-8. [DOI:10.1016/0926-6917(94)90029-9]
29. Nikbakht J, Hemmati AA, Arzi A, Mansouri MT, Rezaie A, Ghafourian M. Protective effect of gallic acid against bleomycin-induced pulmonary fibrosis in rats. Pharmacol Rep 2015;67(6):1061-7. [DOI:10.1016/j.pharep.2015.03.012]
30. Hosseinzadeh H, Sadeghnia HR, Ziaee T, Danaee A. Protective effect of aqueous saffron extract (Crocus sativus L.) and crocin, its active constituent, on renal ischemia-reperfusion-induced oxidative damage in rats. J Pharm Pharm Sci 2005;8(3):387-93.
31. Hosseinzadeh H, Sadeghnia HR. Safranal, a constituent of Crocus sativus (saffron), attenuated cerebral ischemia induced oxidative damage in rat hippocampus. J Pharm Pharm Sci 2005;8(3):394-9.
32. Joukar S, Najafipour H, Khaksari M, Sepehri G, Shahrokhi N, Dabiri S, et al. The effect of saffron consumption on biochemical and histopathological heart indices of rats with myocardial infarction. Cardio vasc Toxicol 2010;10(1):66-71. [DOI:10.1007/s12012-010-9063-1]
33. Ramirez AM, Wongtrakool C, Welch T, Steinmeyer A, Zügel U, Roman J. Vitamin D inhibition of pro-fibrotic effects of transforming growth factor β1 in lung fibroblasts and epithelial cells. J Steroid Biochem 2010;118(3):142-50. [DOI:10.1016/j.jsbmb.2009.11.004]
34. Rahman I, Skwarska E, Henry M, Davis M, O\'Connor CM, FitzGerald MX, et al. Systemic and pulmonary oxidative stress in idiopathic pulmonary fibrosis. Free RadicBiol Med 1999;27(1):60-8. [DOI:10.1016/S0891-5849(99)00035-0]

Add your comments about this article : Your username or Email:

Send email to the article author

© 2020 All Rights Reserved | Iranian Journal of Toxicology

Designed & Developed by : Yektaweb